Drug Profile
Research programme: atypical antipsychotics - FAES Farma
Alternative Names: F-93013-GDLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator FAES Farma
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Psychotic disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Psychotic-disorders in Spain
- 23 Mar 2009 Preclinical trials in Psychotic disorders in Spain (unspecified route)